Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 18/20 | 0.53 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.42 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29656605 | 1.00 | MGLL (0.53) | MGLLPLA2G7ABHD6FAAH | |
| SCHEMBL29779839 | 1.00 | MGLL (0.53) | MGLLPLA2G7ABHD6FAAH | |
| SCHEMBL29656542 | 1.00 | MGLL (0.53) | MGLLPLA2G7ABHD6FAAH | |
| SCHEMBL29656873 | 0.82 | MGLL (0.46) | MGLLPLA2G7ABHD6 | |
| SCHEMBL24433513 | 0.82 | MGLL (0.46) | MGLLPLA2G7ABHD6 | |
| SCHEMBL29657031 | 0.82 | MGLL (0.46) | MGLLPLA2G7ABHD6 | |
| SCHEMBL29656919 | 0.82 | MGLL (0.46) | MGLLPLA2G7ABHD6 | |
| SCHEMBL24433533 | 0.81 | MGLL (0.46) | MGLLPLA2G7ABHD6 | |
| SCHEMBL24433398 | 0.81 | MGLL (0.51) | MGLLPLA2G7ABHD6FAAH | |
| SCHEMBL24433456 | 0.81 | MGLL (0.50) | MGLLFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240018120-A1 | MAGL INHIBITORS | H. LUNDBECK A/S (DK) | 2024-01-18 | — | — | US | disclosed |
| US-20240018120-A1 | MAGL INHIBITORS | H. LUNDBECK A/S (DK) | 2024-01-18 | — | — | US | disclosed |
| US-20240018120-A1 | MAGL INHIBITORS | H. LUNDBECK A/S (DK) | 2024-01-18 | — | — | US | disclosed |
| US-20220153721-A1 | MAGL INHIBITORS | H. LUNDBECK A/S (DK) | 2022-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240018120-A1 | MAGL INHIBITORS | MAG, MAGI3, MAGT1 | MGLL 5/4885PLA2G7 508/4885ABHD6 91/4885 |
| US-20220153721-A1 | MAGL INHIBITORS | MAG, MAGI3, MAGT1 | MGLL 5/4885PLA2G7 508/4885ABHD6 91/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.